C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/498 (2006.01) A61P 35/00 (2006.01) C07D 241/42 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2565237
The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I wherein A is a carbocycle or heterocycle; X is alkylene, NR4C(O), NR4C(S), NR4C(NH), NR4SO, NR4SO2, NR4C(O)NH, NR4C(S)NH, C(O)NR4, C(S)NR4, C(NH)NR4, NR4PO or NR4PO(OH) wherein R4 is H or alkyl; R1 is selected from the group consisting of alkyl, cycloalkyl, aryl or a heterocycle each of which is optionally substituted with hydroxyl, halogen, amino, nitro, alkyl, acyl, alkylsulfonyl or alkoxy; R2 is halogen, hydroxyl, alkyl, acyl or alkoxy each optionally substituted with hydroxyl, halogen, amino, nitro, alkyl, acyl, alkylsulfonyl or alkoxy; R3 is halogen, hydroxyl, alkyl, acyl or alkoxy each optionally substituted with hydroxyl, halogen, amino, nitro, alkyl, acyl, alkylsulfonyl or alkoxy; m is 0-3; n is 0-3; and salts and solvates thereof.
L'invention concerne de nouveaux inhibiteurs de signalisation hedgehog utilisés comme agents thérapeutique dans le traitement de malignités. Lesdits composés sont représentés par la formule générale I dans laquelle A est un carbocycle ou un hétérocycle; X est alkylène, NR4C(O), NR4C(S), NR4C(NH), NR4SO, NR4SO2, NR4C(O)NH, NR4C(S)NH, C(O)NR4, C(S)NR4, C(NH)NR4, NR4PO ou NR4PO(OH), R4 étant H ou alkyle; R1 est sélectionné dans le groupe composé d'alkyle, de cycloalkyle, d'aryle ou d'un hétérocycle, chacun étant éventuellement substitué par hydroxyle, halogène, amino, nitro, alkyle, acyle, alkylsulfonyle ou alkoxy; R2 est halogène, hydroxyle, alkyle, acyle ou alkoxy, chacun éventuellement substitué par hydroxyle, halogène, amino, nitro, alkyle, acyle, alkylsulfonyle ou alkoxy; R3 est halogène, hydroxyle, alkyle, acyle ou alkoxy, chacun éventuellement substitué par hydroxyle, halogène, amino, nitro, alkyle, acyle, alkylsulfonyle ou alkoxy; m est 0-3; et n est 0-3. L'invention concerne également des sels et solvates desdits composés.
Goldsmith Richard
Koehler Michael F. T.
Sutherlin Daniel P.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Curis Inc.
Genentech Inc.
LandOfFree
Quinoxaline inhibitors of hedgehog signalling pathway does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoxaline inhibitors of hedgehog signalling pathway, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoxaline inhibitors of hedgehog signalling pathway will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1780062